Tech Company M&A Transactions
True North Therapeutics Acquisition
True North Therapeutics was bought by Bioverativ. The transaction was announced on 5/26/2017. The parties disclosed the acquisition price to be $825 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/26/2017
Transaction Type
M&A
Amount
$825,000,000
M&A Terms
Bioverativ Inc. (BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, today announced that it has entered into a definitive agreement to acquire South San Francisco-based True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company, for an upfront payment of $400 million plus assumed cash. True North investors are also eligible to receive additional payments of up to $425 million contingent on the achievement of future development, regulatory and sales milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
951 Gateway Blvd.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need. The company's lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition of downstream phagocytosis, inflammation, and cell lysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nancy Stagliano
Chief Financial Officer
Pamela Wapnick
Chief Medical Officer
Gary Patou
VP - Bus. Development
Adam Rosenthal
VP - R & D
Graham Parry
Browse more venture capital transactions:
Prev: 5/26/2017: Rentalutions venture capital transaction
Next: 5/26/2017: Harpoon Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs